mitomycin has been researched along with paclitaxel in 130 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 23 (17.69) | 18.2507 |
2000's | 52 (40.00) | 29.6817 |
2010's | 44 (33.85) | 24.3611 |
2020's | 11 (8.46) | 2.80 |
Authors | Studies |
---|---|
Barrows, LR; Ireland, CM; Kokoshka, JM | 1 |
Chen, CY; Chen, YJ; Hwang, JF; Kuo, YH; Prakash, CV; Shen, YC | 1 |
Chakraborty, R; Chien, CT; Kuo, YH; Lin, YC; Lo, KL; Pan, YL; Shen, YC; Wang, SS | 1 |
Ham, J; Jung, M; Kim, H; Kim, SK; Lee, K; Lee, S | 1 |
Bacsó, Z; Cianfriglia, M; Fenyvesi, F; Goda, K; Kappelmayer, J; Lustyik, G; Nagy, H; Szabó, G; Szilasi, M | 1 |
Bastow, KF; Bruno, M; Lee, KH; Maggio, A; Raccuglia, RA; Rosselli, S | 1 |
Gupta, P; Kumar, A; Qazi, GN; Saxena, AK; Sethi, VK; Shah, BA; Sharma, M; Singh, J; Taneja, SC | 1 |
Agrawal, SK; Bhella, SS; Ishar, MP; Raj, T; Saxena, AK; Singh, L; Singh, R | 1 |
Chou, TC; Dong, H; Kakadiya, R; Kapuriya, K; Kapuriya, N; Lee, PC; Lee, TC; Shah, A; Su, TL; Zhang, X | 1 |
Agrawal, SK; Gupta, PP; Rani, R; Saxena, AK; Singh, J; Sondhi, SM | 1 |
Bhatia, RK; Ishar, MP; Kapur, A; Raj, T; Saxena, AK; Sharma, M | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Benfenati, E; Raska, I; Toropov, AA; Toropova, AP | 1 |
Agrawal, SK; Rani, R; Roy, P; Saxena, AK; Singh, J; Sondhi, SM | 1 |
Ashraf, M; Bhushan, S; Chashoo, G; Kamal, A; Kashi Reddy, M; Kaur, T; Mondhe, DM; Naseer Ahmed Khan, M; Saxena, A; Saxena, AK; Sehar, I; Sharma, PR; Srikanth, YV; Sultana, F; Suri, N; Wani, ZA | 1 |
Bedi, PM; Kaur, T; Kumar, V; Mahajan, MP; Raj, R; Saxena, AK; Singh, P | 1 |
Anand, A; Bedi, PM; Kaur, T; Kumar, V; Saxena, AK; Sharma, P; Singh, P | 1 |
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
Andotra, SS; Gupta, VK; Hamid, A; Johri, S; Kant, R; Kapoor, K; Kaur, T; Kumar, A; Kumar, M; Qadri, M; Riyaz-Ul-Hassan, S; Shah, BA; Sharma, PR; Taneja, SC; Vishwakarma, RA | 1 |
Avery, VM; Sykes, ML | 1 |
Arora, S; Chaudhary, A; Ishar, MP; Saxena, AK; Sharma, V | 1 |
Barua, NC; Buragohain, P; Saikia, B; Saxena, AK; Suri, N; Surineni, N | 1 |
Arora, S; Chaudhry, A; Gupta, V; Ishar, MPS; Kumar, R; Sharma, V; Sood, A | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Hu, M; Li, D; Pei, L; Qiu, Y; Wang, G; Wu, L; Xu, J; Xu, S; Yao, H; Zhu, Z | 1 |
Ahmed, F; Funasaki, M; Ishibashi, M; Kishida, A; Ohsaki, A; Sadhu, SK; Taniguchi, K | 1 |
Cheng, J; Liang, Y; Lin, S; Pan, F; Wang, Y | 1 |
Erlichman, C | 1 |
Abe, K; Fujii, H; Igarashi, T; Itoh, K; Ohtsu, T; Sasaki, Y; Sekine, I; Wakita, H | 1 |
Bruns, C; Raulf, F; Tolcsvai, L; Weckbecker, G | 1 |
Beesley, JS; Hamilton, TC; Johnson, SW; Laub, PB; Ozols, RF | 1 |
Asanuma, F; Hoshiya, Y; Kitajima, M; Koh, JI; Kubota, T; Matsuzaki, SW; Watanabe, M; Yamada, Y | 1 |
Shimizu, Y | 1 |
Fujimura, M; Fushiki, H; Hidaka, T; Hori, S; Izumi, R; Yamakawa, Y | 1 |
Masuda, N | 1 |
Saijo, N | 1 |
Blagosklonny, MV; Fojo, T; Iglesias, A; Zhan, Z | 1 |
Jampel, HD; Moon, JI | 1 |
Cafaggi, S; Esposito, M; Pastrone, I; Pellecchia, C; Vannozzi, MO; Viale, M | 1 |
Au, JL; Gan, Y; Weaver, JR | 1 |
Bagnell, RD; Estes, L; Kelner, MJ; McMorris, TC; Samson, KM; Taetle, R | 1 |
Crown, J; Nabholtz, JM | 1 |
Dubowchik, GM; Firestone, RA; Knipe, JO; Mosure, K | 1 |
Corey, EJ; Martinez, EJ; Owa, T; Schreiber, SL | 1 |
Crown, J | 1 |
Au, JL; Weaver, JR; Wientjes, MG | 1 |
Moiseenko, VM; Orlova, RV | 1 |
Goto, K; Hojo, F; Hosomi, Y; Kakinuma, R; Kodama, K; Matsumoto, T; Mito, K; Moriyama, E; Niho, S; Nishiwaki, Y; Ohe, Y; Ohmatsu, H; Tanaka, K; Uramoto, H | 1 |
Bleicher, RJ; Singh, SV; Xia, H; Zaren, HA | 1 |
Kreienberg, R; Runnebaum, IB; Wu, Q | 1 |
Anthony, SP; Davis, SA; Hamilton, JW; Ihnat, MA; Kaltreider, RC; Lariviere, JP; Nervi, AM; Pesce, CA; Warren, AJ | 1 |
Barret, JM; Etiévant, C; Hill, BT | 1 |
Sandler, A | 1 |
Kubota, T | 1 |
Aoki, H; Fukai, S; Hashimoto, K; Hayashihara, K; Ishida, T; Kuwahara, K; Minegishi, Y; Nemoto, E; Okano, T; Saito, T; Watanabe, K; Watanabe, S; Yanai, N | 1 |
Kobayashi, T; Morikawa, J; Sawa, H; Shiku, H; Zhang, W | 1 |
Gérinière, L; Souquet, PJ | 1 |
Cheng, SC; Luo, D; Xie, Y; Zhou, J | 1 |
Rixe, O | 1 |
Kaneko, M; Oguchi, S; Saida, T; Uhara, H | 1 |
Fujimura, M; Fushiki, H; Izumi, R; Nakashima, A; Saito, S; Yuuki, H | 1 |
Riviere, A | 1 |
Akeshima, R; Iba, T; Itamochi, H; Kamazawa, S; Kanamori, Y; Kigawa, J; Sultana, H; Terakawa, N | 1 |
Fujimura, T; Fushida, S; Kinami, S; Miwa, K; Miyamoto, K; Nao, F; Ninomiya, I; Nishimura, G; Ohta, T; Yokogawa, K | 1 |
Du, CW; Li, DR; Lin, W; Lin, Y; Lin, YC; Wu, MY | 1 |
Emi, M; Inoue, H; Kim, R; Tanabe, K; Toge, T; Uchida, Y | 1 |
Ishihara, A; Nagao, K; Tanaka, H; Toyoda, N; Umekawa, T | 1 |
Gu, M; Ma, D; Wang, C; Wang, S | 1 |
Benedicic, Ch; Petru, E; Pickel, H; Seewann, A | 1 |
Beinke, C; Cordes, N; Plasswilm, L; van Beuningen, D | 1 |
Dekel, Y; Margalit, R; Melikhov, D; Peer, D | 1 |
Cai, SM; Huang, X; Li, ZT; Tang, J; Zang, RY | 1 |
Dan, S; Fukui, Y; Nakamura, T; Nakatsu, N; Yamazaki, K; Yamori, T; Yoshida, Y | 1 |
Ichinose, Y; Okamoto, T | 1 |
Muehlbauer, PA; Schuler, MJ | 1 |
Brody, JR; Cunningham, SC; DeMarzo, AM; Dezentje, DA; Gallmeier, E; Hruban, RH; Isacoff, WH; Kern, SE; Offerhaus, GJ; Swartz, MJ; van der Heijden, MS | 1 |
Baba, H; Beppu, T; Okabe, K; Sano, O; Yamanaka, T | 1 |
Aiko, S; Ishizuka, T; Kumano, I; Maehara, T; Sakano, T; Sugiura, Y; Yoshizumi, Y | 1 |
Matsui, H; Matsuzaki, Y; Miyazaki, K; Nakahara, A; Sato, D; Shibahara, T; Suzuki, H; Uchida, K; Yanaka, A | 1 |
Stuart, OA; Sugarbaker, PH; Yan, TD; Yoo, D | 1 |
Depierre, A | 1 |
Bryan, B; Dezube, BJ; Konstantinopoulos, PA; Pantanowitz, L; Schlecht, HP | 1 |
Ling, MT; Wang, X; Wong, YC; Zhang, X | 1 |
Alvarez, J; Campaña, O; Lamas, M; Lorenzo, D; Pérez, J; Rodríguez, MJ; Veiras, S | 1 |
Okamoto, H; Watanabe, K | 1 |
Hiraoka, M; Imagunbai, T; Inoue, T; Mitsumori, M; Negoro, Y; Sai, H; Sasaki, S; Sasaki, Y; Shikama, N; Takegawa, H; Teshima, T; Yamauchi, C | 1 |
Begossi, G; Belliveau, J; DiSiena, M; Gustafson, E; Wanebo, HJ | 1 |
Cao, YC; Fu, ZJ; Geng, M; Tai, YH; Wang, XY; Yin, YC | 1 |
Cao, YC; Fu, ZJ; Geng, M; Tai, YH; Yin, YC | 1 |
Chen, L; Chen, T; Honma, M; Mei, N; Moore, MM; Sawyer, JR; Wang, J | 1 |
Asanuma, F; Atsuda, K; Hiraku, O; Inoue, G; Morimoto, Y; Sasaki, K; Suzuki, Y; Takeuchi, O; Takizawa, A; Yamada, Y; Yoshizawa, J | 1 |
Kaneno, R; Shurin, GV; Shurin, MR; Tourkova, IL | 1 |
Alvarado-Miranda, A; Arrieta, O; Bargallo-Rocha, E; Gamboa-Vignolle, C; Lara-Medina, F; Morales-Barrera, R; Perez-Sanchez, V; Ramirez-Ugalde, T; Saavedra-Perez, D; Zinser-Sierra, J | 1 |
Chiba, Y; Fukuoka, M; Hida, T; Imamura, F; Iwamoto, Y; Katakami, N; Kawahara, M; Kudo, S; Nakagawa, K; Nishimura, Y; Saka, H; Satouchi, M; Sawa, T; Semba, H; Seto, T; Takeda, K; Tsujino, K; Uejima, H; Yamamoto, N; Yokota, S | 1 |
Askar, SF; Atsma, DE; Bingen, BO; de Vries, AA; Pijnappels, DA; Ramkisoensing, AA; Schalij, MJ; Swildens, J; van der Laarse, A; Ypey, DL | 1 |
Lentz, S; Levine, EA; Parson, EN; Russell, G; Shen, P; Stewart, JH | 1 |
Bachar, G; Cohen, K; Feinmesser, R; Hod, R; Katz, O; Mizrachi, A; Peer, D; Shpitzer, T | 1 |
Arjona-Sánchez, Á; Casado-Adam, Á; Díaz-Nieto, R; Muñoz-Casares, FC; Ortega-Salas, R; Rubio-Pérez, MJ; Rufián-Peña, S | 1 |
Han, X; Wang, L; Xiao, H; Yang, Q | 1 |
Anker, G; Chrisanthar, R; Knappskog, S; Leirvaag, B; Lundgren, S; Løkkevik, E; Lønning, PE; Miletic, H; Mjaaland, I; Risberg, T; Østenstad, B | 1 |
Guthoff, R; Kastner, C; Löbler, M; Schmitz, KP; Stachs, O; Stahnke, T; Sternberg, K; Wree, A | 1 |
Barlow, LJ; Benson, MC | 1 |
Cao, YC; Geng, M; Li, PF; Wang, L; Yin, YC | 1 |
Köhler, R; Krammer, PH; Li-Weber, M; Lüpertz, R; Merz, C; Müller, WW; Natoli, A | 1 |
Ozdemir, O; Ozdemir, P; Ozhan, MH; Uluer, H; Veral, A | 1 |
Chen, N; Pei, YH; Wang, T; Wang, YL; Xu, M; Zhang, J | 1 |
Baxley, A; Khawandanah, M; Pant, S | 1 |
Akgün-Dar, K; Arslan, M; Bilgiç, S; Çetin, B; Engin, KN; Erdem-Kuruca, S; Gürel, E; Karadenizli, S; Yemisci, B | 1 |
Bydder, G; Bydder, M; Carmona, R; Gulaya, S; Mell, LK; Pritz, J; Vaida, F; Welch, CS; Williamson, CW; Zhu, H | 1 |
Harada, A; Matsuzaki, K; Mishima, M; Takeiri, A | 1 |
Ali-El-Dein, B; Babjuk, M; Burger, M; Chang, SS; Clayman, RH; Daneshmand, S; Efstathiou, JA; Fritsche, HM; Gakis, G; Galland, S; Hrbacek, J; Keegan, KA; Mischinger, J; Morgan, TM; Olugbade, K; Rink, M; Schubert, T; Stenzl, A; Thalmann, GN; Todenhöfer, T; Zaid, HB | 1 |
Alexandrov, VA; Belyaev, AM; Belyaeva, OA; Bespalov, VG; Kireeva, GS; Kopteva, OS; Krasilnikova, LA; Maidin, MA; Semenov, AL; Stukov, AN; Vasilieva, IN; Vyshinskaya, EA | 1 |
Fujiwara, Y; Goto, Y; Horinouchi, H; Kanda, S; Nokihara, H; Ohe, Y; Sumi, M; Tamura, T; Yamamoto, N | 1 |
Bai, Z; Du, F; Feng, F; Hang, X; Ji, F; Li, G; Ma, X; Shen, G; Song, E; Xu, B; Zhao, J | 1 |
Ji, ZH; Li, Y; Peng, KW; Sun, JH; Wu, HT; Yonemura, Y; Zhang, Q | 1 |
Wu, AW; Xie, BY | 1 |
Coccia, A; Lendaro, E; Mangino, G; Mosca, L; Puca, R; Rossi, A | 1 |
Barakova, NV; Bespalov, VG; Maidin, MA; Semenov, AL; Stukov, AN; Vasil'eva, IN; Vyshinskaya, EA | 1 |
Barrios, P; Cascales-Campos, P; Esteve-Pérez, N; Morales-Soriano, R; Segura-Sampedro, JJ | 1 |
Rao, S; Sclafani, F | 1 |
Ajani, J; Badgwell, B; Blum Murphy, M; Das, P; Estrella, J; Ikoma, N; Mansfield, P; Minsky, BD; Roy-Chowdhuri, S; Song, S; Wang, X | 1 |
Chambers, L; Chichura, A; Costales, AB; Debernardo, R; Mahdi, H; Michener, CM; Rose, PG; Yao, M | 1 |
Baird, L; Yamamoto, M | 1 |
Arjona-Sanchez, A; Aziz, O; Briceño, J; Casado-Adam, A; Esquivel, J; Glehen, O; Nedelcut, DS; Passot, G; Piso, P; Rodriguez-Ortiz, L; Rufian-Peña, S; Salti, G; Sanchez-Hidalgo, JM; Selvasekar, CR; Sommariva, A; Turaga, K; Van der Speeten, K; Yonemura, Y | 1 |
Chambers, LM; Chichura, A; Costales, AB; Debernardo, R; Gruner, M; Michener, CM; Morton, M; Rose, PG; Vargas, R; Yao, M | 1 |
Jiao, M; Li, C; Mei, N; Tian, T; Zhao, N | 1 |
Dion, GR; Jacobsen, C; Johnson, CM; Luke, AS; Novak, N | 1 |
Hurst, R; Rahman, KMM; Thapa, P; Woo, S; You, Y | 1 |
Ghalami-Choobar, B; Habibzadeh Mashatooki, M | 1 |
Bi, J; Wang, L; Wang, Y | 1 |
17 review(s) available for mitomycin and paclitaxel
Article | Year |
---|---|
Approaches to protozoan drug discovery: phenotypic screening.
Topics: Drug Discovery; Humans; Molecular Structure; Neglected Diseases; Phenotype; Plasmodium falciparum; Protozoan Infections; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosoma cruzi | 2013 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Novel chemotherapeutic agents in clinical development.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Camptothecin; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Humans; Mitomycin; Mitomycins; Paclitaxel; Pyrazoles; Quinazolines; Thiophenes; Topotecan | 1991 |
[Consecutive low-dose cisplatin-based chemotherapy for gynecologic malignancies].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Genital Neoplasms, Female; Humans; Ifosfamide; Mitomycin; Ovarian Neoplasms; Paclitaxel; Uterine Cervical Neoplasms; Uterine Neoplasms; Vincristine | 1997 |
[Combination chemotherapy in the treatment of inoperable non-small cell lung cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Gemcitabine; Humans; Irinotecan; Lung Neoplasms; Meta-Analysis as Topic; Mitomycin; Paclitaxel; Survival Rate; Vinblastine; Vindesine; Vinorelbine | 1997 |
New chemotherapeutic agents for the treatment of non-small cell lung cancer: the Japanese experience.
Topics: Alkaloids; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carbazoles; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Docetaxel; Glucosides; Humans; Irinotecan; Japan; Lung Neoplasms; Mitomycin; Mitomycins; Neoplasms, Experimental; Paclitaxel; Purine Nucleosides; Staurosporine; Taxoids; Treatment Outcome; Vinblastine; Vinorelbine | 1998 |
Phase III randomized trials of docetaxel in patients with metastatic breast cancer.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials, Phase III as Topic; Docetaxel; Humans; Mitomycin; Neoplasm Metastasis; Paclitaxel; Randomized Controlled Trials as Topic; Salvage Therapy; Taxoids; Vinblastine | 1999 |
Chemotherapy in metastatic non-small-cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials as Topic; Deoxycytidine; Docetaxel; Gemcitabine; Humans; Ifosfamide; Irinotecan; Lung Neoplasms; Mitomycin; Paclitaxel; Taxoids; Tirapazamine; Triazines; Vinblastine; Vinorelbine | 2000 |
[Recent advance in gastric cancer chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Screening Assays, Antitumor; Fluorouracil; Humans; Mitomycin; Paclitaxel; Prognosis; RNA, Messenger; Stomach Neoplasms; Taxoids; Thymidylate Synthase | 2000 |
[Chemotherapy of stage IV non-small-cell lung cancer: contribution of gemcitabine].
Topics: Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Deoxycytidine; Gemcitabine; Humans; Ifosfamide; Lung Neoplasms; Mitomycin; Paclitaxel; Prognosis; Randomized Controlled Trials as Topic; Vinblastine; Vinorelbine | 2000 |
[Does treatment for malignant pleural mesothelioma exist?].
Topics: Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Deoxycytidine; Drug Therapy, Combination; Female; Gemcitabine; Glutamates; Guanine; Humans; Immunotherapy; Interferons; Male; Mesothelioma; Middle Aged; Mitomycin; Multivariate Analysis; Paclitaxel; Palliative Care; Pemetrexed; Pleural Neoplasms; Pneumonectomy; Postoperative Care; Radiotherapy Dosage; Time Factors | 2001 |
Palliative cytostatic treatment of cervical carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Camptothecin; Carcinoma, Squamous Cell; Cisplatin; Female; Humans; Irinotecan; Mitomycin; Paclitaxel; Palliative Care; Randomized Controlled Trials as Topic; Survival Analysis; Uterine Cervical Neoplasms; Vindesine | 2003 |
[Postoperative adjuvant chemotherapy for non-small cell lung cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Drug Combinations; Humans; Lung Neoplasms; Meta-Analysis as Topic; Mitomycin; Paclitaxel; Pneumonectomy; Postoperative Care; Randomized Controlled Trials as Topic; Tegafur; Uracil; Vinblastine; Vindesine; Vinorelbine | 2005 |
Comprehensive management of diffuse malignant peritoneal mesothelioma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Doxorubicin; Humans; Hyperthermia, Induced; Mesothelioma; Mitomycin; Paclitaxel; Patient Selection; Peritoneal Neoplasms; Survival Analysis | 2006 |
Experience with newer intravesical chemotherapy for high-risk non-muscle-invasive bladder cancer.
Topics: Administration, Intravesical; Antineoplastic Agents; BCG Vaccine; Carcinoma, Transitional Cell; Deoxycytidine; Docetaxel; Doxorubicin; Gemcitabine; Humans; Mitomycin; Paclitaxel; Taxoids; Thiotepa; Treatment Failure; Urinary Bladder Neoplasms | 2013 |
Systemic Therapies for Advanced Squamous Cell Anal Cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Biomarkers, Tumor; Carcinoma, Squamous Cell; Clinical Trials as Topic; ErbB Receptors; HIV Infections; Humans; Immunotherapy; Mitomycin; Molecular Targeted Therapy; Paclitaxel | 2018 |
State of the Science in Tracheal Stents: A Scoping Review.
Topics: Adult; Alloys; Animals; Arsenic Trioxide; Cats; Dogs; Doxycycline; Humans; Magnesium; Mice; Mitomycin; Paclitaxel; Polydioxanone; Polyesters; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Polytetrafluoroethylene; Polyurethanes; Rats; Sheep; Silicones; Sirolimus; Steel; Stents; Swine; Tracheal Stenosis | 2022 |
6 trial(s) available for mitomycin and paclitaxel
Article | Year |
---|---|
Phase III studies of single-agent docetaxel in patients with metastatic breast cancer who have progressed despite previous chemotherapy regimens: preliminary results.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Docetaxel; Doxorubicin; Female; Humans; Middle Aged; Mitomycin; Neoplasm Metastasis; Paclitaxel; Survival Analysis; Taxoids; Vinblastine | 1998 |
Phase I study of cisplatin and docetaxel plus mitomycin C in patients with metastatic non-small cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Hyponatremia; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neutropenia; Paclitaxel; Taxoids | 1999 |
[Comparison of effects of three chemotherapy regimens for advanced non-small cell lung cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Docetaxel; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Paclitaxel; Taxoids; Treatment Outcome | 2002 |
Phase III study comparing second- and third-generation regimens with concurrent thoracic radiotherapy in patients with unresectable stage III non-small-cell lung cancer: West Japan Thoracic Oncology Group WJTOG0105.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Female; Humans; Irinotecan; Lung Neoplasms; Male; Middle Aged; Mitomycin; Paclitaxel; Radiotherapy, Adjuvant; Vindesine | 2010 |
Low expression levels of ATM may substitute for CHEK2 /TP53 mutations predicting resistance towards anthracycline and mitomycin chemotherapy in breast cancer.
Topics: Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Ataxia Telangiectasia Mutated Proteins; Breast Neoplasms; Cell Cycle Proteins; Checkpoint Kinase 2; Cohort Studies; DNA-Binding Proteins; Doxorubicin; Drug Resistance, Neoplasm; Epirubicin; Female; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; Mitomycin; Mutation; Paclitaxel; Predictive Value of Tests; Promoter Regions, Genetic; Prospective Studies; Protein Serine-Threonine Kinases; Tumor Suppressor Protein p53; Tumor Suppressor Proteins | 2012 |
Phase I Trial of Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) with Cisplatin, Mitomycin, and Paclitaxel in Patients with Gastric Adenocarcinoma and Associated Carcinomatosis or Positive Cytology.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bayes Theorem; Cisplatin; Combined Modality Therapy; Humans; Hyperthermia, Induced; Mitomycin; Paclitaxel; Perfusion; Peritoneal Neoplasms; Stomach Neoplasms | 2020 |
107 other study(ies) available for mitomycin and paclitaxel
Article | Year |
---|---|
Cell-based screen for identification of inhibitors of tubulin polymerization.
Topics: Animals; Brain Neoplasms; Bucladesine; Cell Differentiation; Drug Screening Assays, Antitumor; Formazans; Glioma; Rats; Tubulin; Tumor Cells, Cultured | 1996 |
Taxane diterpenoids from the stem bark of Taxus mairei.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Hepatocellular; Humans; Magnetic Resonance Spectroscopy; Molecular Structure; Paclitaxel; Plant Stems; Plants, Medicinal; Structure-Activity Relationship; Taxoids; Tumor Cells, Cultured | 2001 |
New taxane diterpenoids from the leaves and twigs of Taxus sumatrana.
Topics: Antineoplastic Agents, Phytogenic; Bridged-Ring Compounds; Diterpenes; Drug Screening Assays, Antitumor; Humans; KB Cells; Molecular Structure; Plant Leaves; Plant Stems; Plants, Medicinal; Taxoids; Taxus; Tumor Cells, Cultured | 2002 |
Antitumor activity of novel deoxoartemisinin monomers, dimers, and trimer.
Topics: Animals; Antineoplastic Agents; Artemisinins; Drug Screening Assays, Antitumor; Humans; Mice; Polymers; Sesquiterpenes; Structure-Activity Relationship; Tumor Cells, Cultured | 2003 |
Distinct groups of multidrug resistance modulating agents are distinguished by competition of P-glycoprotein-specific antibodies.
Topics: Adenosine Triphosphatases; Animals; Anti-Bacterial Agents; Antibodies, Monoclonal; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding, Competitive; Calcium Channel Blockers; Cyclosporine; Detergents; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Fluoresceins; Humans; Ivermectin; Mice; NIH 3T3 Cells; Substrate Specificity | 2004 |
Cytotoxic activity of some natural and synthetic guaianolides.
Topics: Antineoplastic Agents, Phytogenic; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Paclitaxel; Sesquiterpenes; Structure-Activity Relationship; Tumor Cells, Cultured | 2005 |
Cytotoxic and apoptotic activities of novel amino analogues of boswellic acids.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Boswellia; Cell Line, Tumor; DNA Fragmentation; Growth Inhibitors; Humans; Triterpenes | 2007 |
Synthesis and cytotoxic activity of some novel polycyclic gamma-butyrolactones.
Topics: 4-Butyrolactone; Antineoplastic Agents; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Growth Inhibitors; Humans; Male; Polycyclic Compounds | 2008 |
Potent antitumor bifunctional DNA alkylating agents, synthesis and biological activities of 3a-aza-cyclopenta[a]indenes.
Topics: Animals; Antineoplastic Agents, Alkylating; Aza Compounds; Breast Neoplasms; Carcinoma; Cell Cycle; Cell Line, Tumor; Cell Survival; Cross-Linking Reagents; DNA; Female; Humans; Indenes; Mice; Mice, Nude; Neoplasms; Remission Induction; Structure-Activity Relationship; Xenograft Model Antitumor Assays | 2009 |
Synthesis, anti-inflammatory and anticancer activity evaluation of some novel acridine derivatives.
Topics: Acridines; Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Carrageenan; Cell Line, Tumor; Cell Proliferation; Edema; Female; Humans; Male; Rats; Structure-Activity Relationship | 2010 |
Cytotoxic activity of 3-(5-phenyl-3H-[1,2,4]dithiazol-3-yl)chromen-4-ones and 4-oxo-4H-chromene-3-carbothioic acid N-phenylamides.
Topics: Amides; Antineoplastic Agents; Cell Line, Tumor; Chromones; Humans; Inhibitory Concentration 50; Structure-Activity Relationship; Thiazoles | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
QSPR modeling of octanol/water partition coefficient of antineoplastic agents by balance of correlations.
Topics: Antineoplastic Agents; Models, Chemical; Octanols; Quantitative Structure-Activity Relationship; Water | 2010 |
Solvent free synthesis, anti-inflammatory and anticancer activity evaluation of tricyclic and tetracyclic benzimidazole derivatives.
Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Benzimidazoles; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Female; Humans; Microwaves; Neoplasms; Ovarian Neoplasms | 2010 |
2-Anilinonicotinyl linked 2-aminobenzothiazoles and [1,2,4]triazolo[1,5-b] [1,2,4]benzothiadiazine conjugates as potential mitochondrial apoptotic inducers.
Topics: Aniline Compounds; Animals; Apoptosis; Benzothiadiazines; Caspases; Cell Cycle; Cell Growth Processes; Cell Line, Tumor; Drug Screening Assays, Antitumor; Growth Inhibitors; Haplorhini; HL-60 Cells; Humans; Mitochondria; Nicotine | 2011 |
1,2,3-Triazole tethered β-lactam-chalcone bifunctional hybrids: synthesis and anticancer evaluation.
Topics: Antineoplastic Agents; beta-Lactams; Cell Line, Tumor; Cell Proliferation; Chalcone; Humans; Inhibitory Concentration 50; Triazoles | 2012 |
Azide-alkyne cycloaddition en route to novel 1H-1,2,3-triazole tethered isatin conjugates with in vitro cytotoxic evaluation.
Topics: Alkynes; Antineoplastic Agents; Azides; Cell Line, Tumor; Cycloaddition Reaction; Humans; Isatin; Triazoles | 2012 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Tubulin inhibitors from an endophytic fungus isolated from Cedrus deodara.
Topics: Apoptosis; Ascomycota; Bridged Bicyclo Compounds, Heterocyclic; Cedrus; Crystallography, X-Ray; HCT116 Cells; HL-60 Cells; Humans; Isocoumarins; Molecular Conformation; Molecular Structure; Tubulin Modulators | 2013 |
β-Ionone derived chalcones as potent antiproliferative agents.
Topics: Animals; Apoptosis; Cell Cycle; Cell Proliferation; Chalcones; CHO Cells; Cricetulus; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; HeLa Cells; Hep G2 Cells; Humans; MCF-7 Cells; Molecular Structure; Norisoprenoids; Structure-Activity Relationship; Tumor Cells, Cultured | 2013 |
Synthesis of a novel series of artemisinin dimers with potent anticancer activity involving Sonogashira cross-coupling reaction.
Topics: Antineoplastic Agents; Artemisinins; Cell Line, Tumor; Cell Proliferation; Dimerization; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; HeLa Cells; Humans; MCF-7 Cells; Molecular Structure; Structure-Activity Relationship | 2014 |
Synthesis and evaluation of 3-salicyloylpyridine derivatives as cytotoxic mitochondrial apoptosis inducers.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Hep G2 Cells; Humans; MCF-7 Cells; Membrane Potential, Mitochondrial; Mitochondria; Models, Molecular; Molecular Structure; Phenols; Pyridines; Reactive Oxygen Species; Structure-Activity Relationship | 2014 |
Design, synthesis, and biological evaluation of NAD(P)H: Quinone oxidoreductase (NQO1)-targeted oridonin prodrugs possessing indolequinone moiety for hypoxia-selective activation.
Topics: A549 Cells; Animals; Antineoplastic Agents; Apoptosis; Cell Proliferation; Diterpenes, Kaurane; Drug Design; Heterografts; HT29 Cells; Humans; Hypoxia; Indolequinones; Mice; Molecular Docking Simulation; NAD(P)H Dehydrogenase (Quinone); Prodrugs | 2017 |
Two new coumarins and a new xanthone from the leaves of Rhizophora mucronata.
Topics: Animals; Cell Survival; Coumarins; Dose-Response Relationship, Drug; HeLa Cells; HL-60 Cells; Humans; Mice; Molecular Structure; NIH 3T3 Cells; Plant Leaves; Rhizophoraceae; Structure-Activity Relationship; Xanthones | 2018 |
Novel diaryl-2H-azirines: Antitumor hybrids for dual-targeting tubulin and DNA.
Topics: Animals; Antineoplastic Agents; Apoptosis; Azirines; Cell Line, Tumor; Cell Proliferation; DNA; DNA Damage; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Structure; Neoplasms, Experimental; Polymerization; Structure-Activity Relationship; Tubulin; Tubulin Modulators | 2021 |
Recurrent breast cancer treated successfully with mitomycin-C and vinblastine after failure of both doxorubicin-containing regimen and paclitaxel--a case report.
Topics: Adenocarcinoma, Scirrhous; Adult; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Breast Neoplasms; Doxorubicin; Female; Humans; Mitomycin; Paclitaxel; Radiography; Recurrence; Treatment Failure; Vinblastine | 1996 |
Potentiation of the anti-proliferative effects of anti-cancer drugs by octreotide in vitro and in vivo.
Topics: Animals; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Autoradiography; Cell Division; Doxorubicin; Drug Synergism; Fluorouracil; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Mitomycin; Neoplasm Transplantation; Octreotide; Paclitaxel; Pancreatic Neoplasms; Polymerase Chain Reaction; Tumor Cells, Cultured | 1996 |
Increased platinum-DNA damage tolerance is associated with cisplatin resistance and cross-resistance to various chemotherapeutic agents in unrelated human ovarian cancer cell lines.
Topics: Antineoplastic Agents; Cisplatin; DNA Damage; DNA Repair; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance; Etoposide; Female; Glutathione; Humans; Mitomycin; Ovarian Neoplasms; Paclitaxel; Regression Analysis; Tumor Cells, Cultured | 1997 |
Antitumor activity of paclitaxel against human breast carcinoma xenografts serially transplanted into nude mice.
Topics: Animals; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Coloring Agents; Cyclophosphamide; Doxorubicin; Drug Resistance, Neoplasm; Female; Humans; Mice; Mice, Nude; Mitomycin; Neoplasm Transplantation; Paclitaxel; Tetrazolium Salts; Thiazoles; Transplantation, Heterologous; Tumor Cells, Cultured | 1997 |
[Evaluation of a new anti-cancer drug regimen against uterine cervical cancer in nude mice].
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Camptothecin; Carcinoma, Squamous Cell; Cisplatin; Female; Fluorouracil; Humans; Irinotecan; Mice; Mice, Nude; Mitomycin; Neoplasm Transplantation; Paclitaxel; Uterine Cervical Neoplasms | 1997 |
Like p53, the proliferation-associated protein p120 accumulates in human cancer cells following exposure to anticancer drugs.
Topics: Antineoplastic Agents; Base Sequence; Cell Division; Dactinomycin; Daunorubicin; DNA Damage; DNA Primers; Doxorubicin; Humans; Microtubules; Mitomycin; Neoplasm Proteins; Nuclear Proteins; Paclitaxel; Polymerase Chain Reaction; Transcription, Genetic; tRNA Methyltransferases; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Vincristine | 1998 |
The effect of paclitaxel powder on glaucoma filtration surgery in rabbits.
Topics: Animals; Antineoplastic Agents, Phytogenic; Conjunctiva; Filtering Surgery; Glaucoma; Intraocular Pressure; Intraoperative Period; Mitomycin; Ophthalmic Solutions; Paclitaxel; Powders; Rabbits; Random Allocation; Sclera; Treatment Outcome | 1998 |
Combination of cisplatin-procaine complex DPR with anticancer drugs increases cytotoxicity against ovarian cancer cell lines.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Female; Fluorouracil; Humans; Methotrexate; Microtubules; Mitomycin; Organoplatinum Compounds; Ovarian Neoplasms; Paclitaxel; Procaine; Tumor Cells, Cultured | 1998 |
Proliferation indices as molecular pharmacodynamic endpoints in evaluation of anticancer drug effect in human solid tumors.
Topics: Antineoplastic Agents; Bromodeoxyuridine; Cell Division; DNA; Doxorubicin; Humans; Mitomycin; Neoplasms; Paclitaxel; Proliferating Cell Nuclear Antigen; Thymidine | 1998 |
Efficacy of MGI 114 (6-hydroxymethylacylfulvene, HMAF) against the mdr1/gp170 metastatic MV522 lung carcinoma xenograft.
Topics: Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Drug Resistance, Neoplasm; Female; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mitomycin; Neoplasm Transplantation; Paclitaxel; Sesquiterpenes; Transplantation, Heterologous; Tumor Cells, Cultured | 1998 |
Cathepsin B-sensitive dipeptide prodrugs. 2. Models of anticancer drugs paclitaxel (Taxol), mitomycin C and doxorubicin.
Topics: Animals; Cathepsin B; Dipeptides; Doxorubicin; Drug Carriers; Drug Stability; Humans; Mitomycin; Paclitaxel; Prodrugs; Rats | 1998 |
Phthalascidin, a synthetic antitumor agent with potency and mode of action comparable to ecteinascidin 743.
Topics: Antineoplastic Agents, Alkylating; Bleomycin; Camptothecin; Cell Division; Cisplatin; Cross-Linking Reagents; Dioxoles; DNA Topoisomerases, Type I; DNA, Neoplasm; Doxorubicin; Etoposide; Female; Humans; Isoquinolines; Male; Mitomycin; Models, Molecular; Molecular Structure; Neoplasm Proteins; Paclitaxel; Phthalimides; Structure-Activity Relationship; Tetrahydroisoquinolines; Trabectedin; Tumor Cells, Cultured | 1999 |
Regional heterogeneity and pharmacodynamics in human solid tumor histoculture.
Topics: Antineoplastic Agents; Carcinoma, Transitional Cell; Cell Division; Culture Techniques; Drug Screening Assays, Antitumor; Floxuridine; Humans; Image Processing, Computer-Assisted; Mitomycin; Paclitaxel; Urinary Bladder Neoplasms | 1999 |
[Effectiveness of current chemotherapy in metastatic breast cancer resistant to anthracycline antibiotics].
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Doxorubicin; Drug Resistance, Neoplasm; Female; Humans; Methotrexate; Middle Aged; Mitomycin; Mitoxantrone; Neoplasm Staging; Paclitaxel; Retrospective Studies; Treatment Outcome; Vinblastine; Vinorelbine | 1999 |
Biochemical mechanism of cross-resistance to paclitaxel in a mitomycin c-resistant human bladder cancer cell line.
Topics: Antineoplastic Agents; Apoptosis; DNA Damage; Drug Resistance, Neoplasm; Humans; Mitomycin; Paclitaxel; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 2000 |
Growth suppression of human ovarian carcinoma OV-MZ-2a and OV-MZ-32 cells mediated by gene transfer of wild-type p53 enhanced by chemotherapy in vitro.
Topics: Adenocarcinoma; Adenoviridae; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Cisplatin; Doxorubicin; Female; Gene Deletion; Gene Expression Regulation, Neoplastic; Gene Transfer Techniques; Genetic Vectors; Humans; Mitomycin; Mutation, Missense; Ovarian Neoplasms; Paclitaxel; Transduction, Genetic; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Up-Regulation | 2000 |
Effects of mitomycin C and carboplatin pretreatment on multidrug resistance-associated P-glycoprotein expression and on subsequent suppression of tumor growth by doxorubicin and paclitaxel in human metastatic breast cancer xenografted nude mice.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Carboplatin; Doxorubicin; Drug Interactions; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Mice; Mice, Nude; Mitomycin; Neoplasm Proteins; Paclitaxel; Transplantation, Heterologous; Tumor Cells, Cultured | 1999 |
In vitro synergistic effects of vinflunine, a novel fluorinated vinca alkaloid, in combination with other anticancer drugs.
Topics: Antineoplastic Agents, Phytogenic; Camptothecin; Cell Division; Cisplatin; Deoxycytidine; Dose-Response Relationship, Drug; Doxorubicin; Drug Evaluation; Drug Synergism; Drug Therapy, Combination; Etoposide; Fluorouracil; Gemcitabine; Humans; Mitomycin; Models, Chemical; Paclitaxel; Tumor Cells, Cultured; Vinblastine; Vinorelbine | 2000 |
[Effectiveness of docetaxel plus cisplatin in large cell lung cancer showing little response to prior chemotherapy with MVP].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Cisplatin; Docetaxel; Drug Administration Schedule; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Paclitaxel; Taxoids; Treatment Failure; Vindesine | 2000 |
Bax induction activates apoptotic cascade via mitochondrial cytochrome c release and Bax overexpression enhances apoptosis induced by chemotherapeutic agents in DLD-1 colon cancer cells.
Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Caspases; Cisplatin; Colonic Neoplasms; Cytochrome c Group; Doxorubicin; Fluorouracil; Humans; In Situ Nick-End Labeling; Kinetics; Mitochondria; Mitomycin; Paclitaxel; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Recombinant Proteins; Transfection; Tumor Cells, Cultured | 2000 |
Study of multi-drug resistant mechanisms in a taxol-resistant hepatocellular carcinoma QGY-TR 50 cell line.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Hepatocellular; Cell Survival; Dactinomycin; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; Inhibitory Concentration 50; Mitomycin; Paclitaxel; Protein Isoforms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Neoplasm; Time Factors; Tubulin; Tumor Cells, Cultured; Vinblastine; Vincristine | 2001 |
[Concomitant radiochemotherapy for non-small-cell lung cancer: towards an ideal strategy].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Deoxycytidine; Gemcitabine; Humans; Ifosfamide; Immunologic Factors; Lung Neoplasms; Mitomycin; Neoplasm Metastasis; Paclitaxel; Radiation-Sensitizing Agents; Randomized Controlled Trials as Topic; Vinblastine; Vinorelbine | 2001 |
Docetaxel induced durable response in advanced extramammary Paget's disease: a case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Administration Schedule; Epirubicin; Fluorouracil; Humans; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Paclitaxel; Paget Disease, Extramammary; Radiography; Scrotum; Skin Neoplasms; Taxoids; Vincristine | 2002 |
[Apoptosis as a measure of chemosensitivity to anti-cancer drugs in gynecological cancer].
Topics: Animals; Antineoplastic Agents; Apoptosis; Camptothecin; Cisplatin; Drug Screening Assays, Antitumor; Female; Humans; In Situ Nick-End Labeling; Irinotecan; Mice; Mice, Nude; Mitomycin; Neoplasm Transplantation; Ovarian Neoplasms; Paclitaxel; Tumor Cells, Cultured; Uterine Neoplasms | 2002 |
Sensitivity to anticancer agents and resistance mechanisms in clear cell carcinoma of the ovary.
Topics: Adenocarcinoma, Clear Cell; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Camptothecin; Cisplatin; Coloring Agents; DNA Topoisomerases, Type I; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Etoposide; Female; Glutathione; Humans; Inhibitory Concentration 50; Irinotecan; Mitochondrial Proteins; Mitomycin; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Ovarian Neoplasms; Paclitaxel; Reverse Transcriptase Polymerase Chain Reaction; Ribosomal Proteins; RNA, Messenger; Saccharomyces cerevisiae Proteins; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 2002 |
[Pharmacologic study of intraperitoneal docetaxel in gastric cancer patients with peritoneal dissemination].
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Female; Humans; Infusions, Parenteral; Male; Middle Aged; Mitomycin; Paclitaxel; Peritoneal Neoplasms; Stomach Neoplasms; Taxoids; Vindesine | 2002 |
Antisense Bcl-2 and HER-2 oligonucleotide treatment of breast cancer cells enhances their sensitivity to anticancer drugs.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Breast Neoplasms; Cell Division; Cell Line, Tumor; Docetaxel; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drug Resistance, Neoplasm; Humans; Inhibitory Concentration 50; Mitomycin; Oligonucleotides; Oligonucleotides, Antisense; Paclitaxel; Prognosis; Proto-Oncogene Proteins c-bcl-2; Receptor, ErbB-2; Signal Transduction; Taxoids; Time Factors | 2003 |
Salvage chemotherapy with a combination of irinotecan hydrochloride and mitomycin C in platinum- and paclitaxel-resistant epithelial ovarian cancer: case reports.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Camptothecin; Carcinoma; Cisplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Humans; Infusions, Intravenous; Irinotecan; Middle Aged; Mitomycin; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Prognosis; Salvage Therapy; Sampling Studies; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2003 |
Comparative study on three chemotherapeutic regimens for the treatment of advanced epithelial ovarian cancer.
Topics: Adult; Aged; Aged, 80 and over; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cystadenocarcinoma, Mucinous; Cystadenocarcinoma, Serous; Doxorubicin; Female; Humans; Middle Aged; Mitomycin; Ovarian Neoplasms; Paclitaxel; Retrospective Studies; Survival Rate; Taxoids; Treatment Outcome | 2000 |
Irradiation and various cytotoxic drugs enhance tyrosine phosphorylation and beta(1)-integrin clustering in human A549 lung cancer cells in a substratum-dependent manner in vitro.
Topics: Analysis of Variance; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Blotting, Western; Cell Adhesion; Cell Line, Tumor; Cell Survival; Cisplatin; Colony-Forming Units Assay; Extracellular Matrix Proteins; Fibronectins; Fluorescent Antibody Technique; Humans; Integrin beta Chains; Lung Neoplasms; Microscopy, Confocal; Mitomycin; Paclitaxel; Phosphorylation; Polystyrenes; Radiation Dosage; Radiation Tolerance; Radiation-Sensitizing Agents; Signal Transduction; Tyrosine | 2004 |
Fluoxetine inhibits multidrug resistance extrusion pumps and enhances responses to chemotherapy in syngeneic and in human xenograft mouse tumor models.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Lewis Lung; Cell Line, Tumor; Disease Progression; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Female; Fluoxetine; Humans; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Mice, Nude; Mitomycin; Neoplasms, Experimental; Paclitaxel; Tissue Distribution; Vinblastine; Xenograft Model Antitumor Assays | 2004 |
[Multidisciplinary treatment of recurrent epithelial ovarian carcinoma and prognostic analysis].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Female; Humans; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Ovarian Neoplasms; Paclitaxel; Prognosis; Survival Rate; Treatment Outcome | 2004 |
Chemosensitivity profile of cancer cell lines and identification of genes determining chemosensitivity by an integrated bioinformatical approach using cDNA arrays.
Topics: Antineoplastic Agents; Camptothecin; Cell Line, Tumor; Cluster Analysis; Computational Biology; Databases as Topic; DNA, Complementary; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Irinotecan; Mitomycin; Oligonucleotide Array Sequence Analysis; Paclitaxel; Phylogeny; Sensitivity and Specificity; Tissue Distribution; Transfection; Vinblastine; Vinorelbine | 2005 |
Detection of numerical chromosomal aberrations by flow cytometry: a novel process for identifying aneugenic agents.
Topics: Adult; Aneugens; Cells, Cultured; Chromosome Aberrations; Etoposide; Female; Flow Cytometry; Griseofulvin; Humans; Lymphocytes; Male; Mitomycin; Mitosis; Mutagenicity Tests; Paclitaxel; Polyploidy | 2005 |
In vivo therapeutic responses contingent on Fanconi anemia/BRCA2 status of the tumor.
Topics: Animals; Antineoplastic Agents; Apoptosis; BRCA2 Protein; Caspases; Cell Cycle; Cell Line, Tumor; Cell Survival; Chlorambucil; Cisplatin; Cross-Linking Reagents; Deoxycytidine; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Fanconi Anemia Complementation Group C Protein; Fanconi Anemia Complementation Group G Protein; Fanconi Anemia Complementation Group Proteins; Female; Fluorouracil; Gemcitabine; Humans; Inhibitory Concentration 50; Melphalan; Mice; Mice, Nude; Mitomycin; Mutation; Paclitaxel; Pancreatic Neoplasms; Time Factors; Vinblastine; Xenograft Model Antitumor Assays | 2005 |
[A case of advanced gastric cancer with liver and lung metastases markedly responded to TS-1-based sequential chemotherapy].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoembryonic Antigen; Cisplatin; Docetaxel; Drug Administration Schedule; Drug Combinations; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Mitomycin; Oxonic Acid; Paclitaxel; Pyridines; Remission Induction; Taxoids; Tegafur | 2005 |
[A case of gastric cancer with peritoneal dissemination who achieved five-year survival by successive treatments with TS-1 alone and in combination with other drugs].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Drug Administration Schedule; Drug Combinations; Humans; Irinotecan; Male; Mitomycin; Oxonic Acid; Paclitaxel; Peritoneal Neoplasms; Pyridines; Stomach Neoplasms; Survivors; Tegafur | 2006 |
Influence of chemotherapeutic agents and cytokines on the expression of 5-fluorouracil-associated enzymes in human colon cancer cell lines.
Topics: Antimetabolites, Antineoplastic; Apoptosis; Caco-2 Cells; Camptothecin; Cell Line, Tumor; Cisplatin; Colonic Neoplasms; Cytokines; Dihydrouracil Dehydrogenase (NADP); Fluorouracil; HT29 Cells; Humans; Interferons; Ligands; Mitomycin; Orotate Phosphoribosyltransferase; Paclitaxel; RNA, Messenger; Thymidine Phosphorylase; Thymidylate Synthase | 2006 |
[Current data concerning neoadjuvant chemotherapy].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Humans; Ifosfamide; Lung; Lung Neoplasms; Mitomycin; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Radiotherapy Dosage; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Risk; Time Factors | 2006 |
HIV-associated anal squamous cell cancer: an otherwise preventable disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Anus Neoplasms; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Colostomy; Fatal Outcome; Fluorouracil; HIV Infections; Homosexuality, Male; Humans; Laparotomy; Male; Middle Aged; Mitomycin; Paclitaxel; Palliative Care; Radiotherapy, Adjuvant | 2006 |
Evidence of a novel antiapoptotic factor: role of inhibitor of differentiation or DNA binding (Id-1) in anticancer drug-induced apoptosis.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carcinoma, Hepatocellular; Catechin; Cell Line, Tumor; Cell Survival; Cisplatin; Down-Regulation; Doxorubicin; Etoposide; Female; HeLa Cells; Humans; Inhibitor of Differentiation Protein 1; Liver Neoplasms; Male; Mechlorethamine; Methotrexate; Mitomycin; Nasopharyngeal Neoplasms; Paclitaxel; Prostatic Neoplasms; Vincristine | 2007 |
[Anesthetic management for scheduled peritonectomy and hyperthermic intraperitoneal chemotherapy in 20 patients].
Topics: Adult; Aged; Analgesia, Epidural; Anesthesia, General; Anesthesia, Inhalation; Anesthesia, Intravenous; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Colloids; Combined Modality Therapy; Crystalloid Solutions; Diuretics; Erythrocyte Transfusion; Female; Fever; Fluid Therapy; Fluorouracil; Humans; Hyperthermia, Induced; Hypotension; Intraoperative Complications; Isotonic Solutions; Male; Middle Aged; Mitomycin; Monitoring, Intraoperative; Paclitaxel; Peritoneal Neoplasms; Peritoneum; Plasma; Postoperative Complications; Prospective Studies; Vasoconstrictor Agents | 2006 |
[Medical treatment for stage III non-small-cell lung cancer (NSCLC)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Gefitinib; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Mitomycin; Neoplasm Staging; Paclitaxel; Pneumonectomy; Quinazolines; Radiotherapy Dosage; Radiotherapy, Adjuvant; Survival Rate | 2007 |
Patterns of care study of breast-conserving therapy in Japan: comparison of the treatment process between 1995 1997 and 1999 2001 surveys.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Female; Humans; Japan; Lymphatic Metastasis; Mastectomy, Segmental; Methotrexate; Middle Aged; Mitomycin; Mitoxantrone; Neoplasm Staging; Paclitaxel; Population Surveillance; Practice Patterns, Physicians'; Radiotherapy, Adjuvant; Tamoxifen; Vinblastine; Vincristine | 2007 |
Isolated chemotherapeutic perfusion of pelvis as neoadjuvant or palliative therapy for advanced cancer of the rectum.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; Female; Fluorouracil; Humans; Male; Middle Aged; Mitomycin; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Palliative Care; Rectal Neoplasms | 2008 |
[Anti-tumor effects of chemotherapeutic drugs on human gastric cancer cells in vitro and the relationship with expression of hTERT mRNA].
Topics: Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary; Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carcinoma, Signet Ring Cell; Cell Proliferation; Cisplatin; Doxorubicin; Drug Resistance, Neoplasm; Female; Fluorouracil; Humans; Male; Middle Aged; Mitomycin; Paclitaxel; RNA, Messenger; Stomach Neoplasms; Telomerase | 2007 |
[Anti-tumor effect of chemotherapeutic drugs on human gastric cancer cells in vitro and the relationship with Bcl-2 expression].
Topics: Adult; Aged; Antineoplastic Agents; Cell Survival; Cisplatin; Doxorubicin; Drug Screening Assays, Antitumor; Female; Fluorouracil; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Paclitaxel; Proto-Oncogene Proteins c-bcl-2; Stomach Neoplasms; Tumor Cells, Cultured | 2008 |
The mouse lymphoma assay detects recombination, deletion, and aneuploidy.
Topics: Aneuploidy; Animals; Antimetabolites; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Proliferation; Chromosomes, Mammalian; Cytogenetic Analysis; Gene Deletion; Gene Dosage; Loss of Heterozygosity; Lymphoma; Metaphase; Mice; Mitomycin; Mutagenicity Tests; Mutagens; Nucleic Acid Synthesis Inhibitors; Paclitaxel; Recombination, Genetic; Thymidine Kinase; Zidovudine | 2009 |
Experimental study of combination therapy with S-1 against pancreatic cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Camptothecin; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cisplatin; Deoxycytidine; Doxorubicin; Drug Combinations; Drug Synergism; Drug Therapy, Combination; Female; Fluorouracil; Gemcitabine; Humans; Inhibitory Concentration 50; Irinotecan; Mice; Mice, Inbred BALB C; Mitomycin; Oxonic Acid; Paclitaxel; Pancreatic Neoplasms; Pyridines; Tegafur; Xenograft Model Antitumor Assays | 2009 |
Chemotherapeutic agents in noncytotoxic concentrations increase antigen presentation by dendritic cells via an IL-12-dependent mechanism.
Topics: Animals; Antibiotics, Antineoplastic; Antigen Presentation; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Cell Differentiation; Cells, Cultured; Dendritic Cells; Dose-Response Relationship, Drug; Dose-Response Relationship, Immunologic; Doxorubicin; Interleukin-12; Male; Methotrexate; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitomycin; Paclitaxel; Up-Regulation | 2009 |
Concurrent chemo-radiotherapy following neoadjuvant chemotherapy in locally advanced breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Deoxycytidine; Doxorubicin; Female; Fluorouracil; Gemcitabine; Humans; Middle Aged; Mitomycin; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Prognosis; Radiotherapy Dosage; Retrospective Studies; Survival Rate; Treatment Outcome | 2009 |
Antiproliferative treatment of myofibroblasts prevents arrhythmias in vitro by limiting myofibroblast-induced depolarization.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Division; Cells, Cultured; Coculture Techniques; Dose-Response Relationship, Drug; Fibroblasts; Heart Ventricles; Mitomycin; Myocardium; Myocytes, Cardiac; Nucleic Acid Synthesis Inhibitors; Paclitaxel; Patch-Clamp Techniques; Rats; Tachycardia | 2011 |
Outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface dissemination from ovarian neoplasms.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Cancer, Regional Perfusion; Combined Modality Therapy; Databases, Factual; Female; Humans; Hyperthermia, Induced; Infusions, Parenteral; Middle Aged; Mitomycin; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Peritoneum | 2011 |
Hyaluronan-grafted particle clusters loaded with Mitomycin C as selective nanovectors for primary head and neck cancers.
Topics: Adult; Aged; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Drug Carriers; Female; Head and Neck Neoplasms; Humans; Hyaluronan Receptors; Hyaluronic Acid; Male; Materials Testing; Mice; Middle Aged; Mitomycin; Nanostructures; Paclitaxel; Particle Size | 2011 |
Pseudomyxoma peritonei treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: results from a single centre.
Topics: Antineoplastic Agents; Chemotherapy, Cancer, Regional Perfusion; Humans; Hyperthermia, Induced; Mitomycin; Paclitaxel; Peritoneal Neoplasms; Pseudomyxoma Peritonei | 2011 |
[Classification of anticancer drugs with different mechanisms based on amino-acid consumption profiling in culture media].
Topics: Amino Acids; Antineoplastic Agents; Chromatography, High Pressure Liquid; Culture Media; HeLa Cells; Humans; Metabolomics; Mitomycin; Paclitaxel; Spectrometry, Fluorescence | 2011 |
Different fibroblast subpopulations of the eye: a therapeutic target to prevent postoperative fibrosis in glaucoma therapy.
Topics: Adipose Tissue; Cell Culture Techniques; Cell Proliferation; Choroid; Extracellular Matrix Proteins; Fibroblasts; Fibrosis; Fluorescent Antibody Technique, Indirect; Glaucoma; Glaucoma Drainage Implants; Humans; Immunoblotting; Mitomycin; Paclitaxel; Sclera; Tenon Capsule; Trabecular Meshwork; Trabeculectomy; Transforming Growth Factor beta1 | 2012 |
Correlation between chemosensitivity to anticancer drugs and telomerase reverse transcriptase mRNA expression in gastric cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary; Antineoplastic Agents; Biomarkers, Tumor; Carcinoma, Signet Ring Cell; Case-Control Studies; Cell Differentiation; Cell Survival; Cisplatin; Doxorubicin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Fluorouracil; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; In Situ Hybridization; Mitomycin; Neoplasm Grading; Paclitaxel; RNA, Messenger; Stomach Neoplasms; Telomerase; Tumor Cells, Cultured | 2013 |
Targeting the IL-4/IL-13 signaling pathway sensitizes Hodgkin lymphoma cells to chemotherapeutic drugs.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; bcl-X Protein; Cell Line, Tumor; Doxorubicin; Enzyme Activation; Etoposide; Fluorouracil; Hodgkin Disease; Humans; Interleukin-13; Interleukin-4; Mitomycin; Paclitaxel; Promoter Regions, Genetic; Reed-Sternberg Cells; RNA Interference; RNA, Small Interfering; Signal Transduction; STAT6 Transcription Factor | 2013 |
ERCC1 expression does not predict survival and treatment response in advanced stage non-small cell lung cancer cases treated with platinum based chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; DNA-Binding Proteins; Docetaxel; Endonucleases; Female; Follow-Up Studies; Glutamates; Guanine; Humans; Ifosfamide; Immunoenzyme Techniques; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Pemetrexed; Prognosis; Retrospective Studies; Survival Rate; Taxoids | 2013 |
[The influence of mitomycin C and paclitaxel on the proliferation and apoptosis of human pulmonary fibroblast].
Topics: Apoptosis; Cell Proliferation; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Drug-Eluting Stents; Fibroblasts; Flow Cytometry; Humans; Lung; Mitomycin; Paclitaxel | 2013 |
Recurrent metastatic anal cancer treated with modified paclitaxel, ifosfamide, and cisplatin and third-line mitomycin/cetuximab.
Topics: Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Carcinoma, Squamous Cell; Cetuximab; Cisplatin; Humans; Ifosfamide; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Paclitaxel | 2015 |
The evaluation of human tenon's fibroblasts and endothelial cell responses to antifibrotics alone and in combination with α-tocopherol.
Topics: Alkylating Agents; alpha-Tocopherol; Antioxidants; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Cells, Cultured; Cytochromes c; Drug Combinations; Fibroblasts; Flow Cytometry; Fluorouracil; Human Umbilical Vein Endothelial Cells; Humans; Mitomycin; Necrosis; Paclitaxel; Proto-Oncogene Proteins c-bcl-2; Tenon Capsule | 2015 |
Fat composition changes in bone marrow during chemotherapy and radiation therapy.
Topics: Adipose Tissue; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Blood Cell Count; Bone Marrow; Bone Marrow Cells; Capecitabine; Cervical Vertebrae; Cetuximab; Chemoradiotherapy; Cisplatin; Deoxycytidine; Endometrial Neoplasms; Female; Fluorouracil; Humans; Lumbar Vertebrae; Magnetic Resonance Imaging; Male; Middle Aged; Mitomycin; Paclitaxel; Prospective Studies; Prostatic Neoplasms; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Rectal Neoplasms; Spine; Thoracic Vertebrae; Uterine Cervical Neoplasms | 2014 |
The predominant role of apoptosis in γH2AX formation induced by aneugens is useful for distinguishing aneugens from clastogens.
Topics: Aneugens; Apoptosis; Cells, Cultured; DNA Damage; Etoposide; Histones; Humans; Micronucleus Tests; Mitomycin; Mutagens; Paclitaxel; Vinblastine | 2014 |
Impact of perioperative chemotherapy on survival in patients with advanced primary urethral cancer: results of the international collaboration on primary urethral carcinoma.
Topics: Adenocarcinoma; Aged; Albumin-Bound Paclitaxel; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Chemoradiotherapy; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Deoxycytidine; Disease-Free Survival; Female; Fluorouracil; Gemcitabine; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Middle Aged; Mitomycin; Neoadjuvant Therapy; Paclitaxel; Perioperative Care; Retrospective Studies; Urethra; Urethral Neoplasms; Urinary Diversion | 2015 |
[Intraperitoneal chemotherapy--a method of improving treatment effectiveness in ovarian cancer].
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Deoxycytidine; Female; Gemcitabine; Infusions, Intravenous; Infusions, Parenteral; Maximum Tolerated Dose; Melphalan; Mitomycin; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Rats; Rats, Wistar; Triazines | 2015 |
Candidates for Intensive Local Treatment in cIIIA-N2 Non-Small Cell Lung Cancer: Deciphering the Heterogeneity.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Female; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Patient Selection; Radiotherapy Dosage; Vinblastine; Vinorelbine | 2016 |
Cross-talk between EPAS-1/HIF-2α and PXR signaling pathway regulates multi-drug resistance of stomach cancer cell.
Topics: Active Transport, Cell Nucleus; Basic Helix-Loop-Helix Transcription Factors; Cell Line; Cell Nucleus; Cell Proliferation; Cytochrome P-450 CYP3A; Drug Resistance, Multiple; Enhancer Elements, Genetic; Gene Expression Regulation; Humans; Mitomycin; Paclitaxel; Pregnane X Receptor; Promoter Regions, Genetic; Receptors, Steroid; Signal Transduction; Stomach Neoplasms | 2016 |
Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy for the treatment of primary peritoneal serous carcinoma: Results of a Chinese retrospective study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Chemotherapy, Cancer, Regional Perfusion; China; Cisplatin; Combined Modality Therapy; Cytoreduction Surgical Procedures; Docetaxel; Female; Humans; Hyperthermia, Induced; Kaplan-Meier Estimate; Middle Aged; Mitomycin; Paclitaxel; Peritoneal Neoplasms; Retrospective Studies; Taxoids | 2016 |
Organoid Culture of Isolated Cells from Patient-derived Tissues with Colorectal Cancer.
Topics: Adult; Animals; Antineoplastic Agents; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Doxorubicin; Humans; Immunohistochemistry; Male; Mice; Mice, Inbred BALB C; Mitomycin; Organoids; Paclitaxel; Rectal Neoplasms; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2016 |
Extra-virgin olive oil phenols block cell cycle progression and modulate chemotherapeutic toxicity in bladder cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Shape; Cell Survival; Drug Screening Assays, Antitumor; G2 Phase Cell Cycle Checkpoints; Humans; Mitomycin; Olive Oil; Paclitaxel; Phenols; Reactive Oxygen Species | 2016 |
Comparative Study of Antitumor Efficiency of Intraperitoneal and Intravenous Cytostatics in Experimental Rats with Disseminated Ovarian Cancer.
Topics: Adenocarcinoma, Papillary; Animals; Antineoplastic Agents; Ascites; Cisplatin; Female; Injections, Intraperitoneal; Injections, Intravenous; Melphalan; Mitomycin; Neoplasm Transplantation; Ovarian Neoplasms; Paclitaxel; Rats; Survival Analysis; Treatment Outcome; Triazines | 2017 |
Current practice in cytoreductive surgery and HIPEC for metastatic peritoneal disease: Spanish multicentric survey.
Topics: Antineoplastic Agents; Carcinoma; Cardiac Output; Cisplatin; Colorectal Neoplasms; Cytoreduction Surgical Procedures; Female; Humans; Hyperthermia, Induced; Infusions, Parenteral; Male; Mesothelioma; Mitomycin; Monitoring, Intraoperative; Organoplatinum Compounds; Ovarian Neoplasms; Oxaliplatin; Paclitaxel; Peritoneal Neoplasms; Practice Patterns, Physicians'; Spain; Stomach Neoplasms; Surveys and Questionnaires | 2018 |
Effect of platinum sensitivity on the efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) in recurrent epithelial ovarian cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Ovarian Epithelial; Cisplatin; Combined Modality Therapy; Cytoreduction Surgical Procedures; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Humans; Hyperthermic Intraperitoneal Chemotherapy; Kaplan-Meier Estimate; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Ovarian Neoplasms; Paclitaxel; Retrospective Studies; Time Factors | 2021 |
NRF2-Dependent Bioactivation of Mitomycin C as a Novel Strategy To Target KEAP1-NRF2 Pathway Activation in Human Cancer.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Cisplatin; Doxorubicin; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Genes, Reporter; Green Fluorescent Proteins; Humans; Kelch-Like ECH-Associated Protein 1; Luminescent Proteins; Mitomycin; NAD(P)H Dehydrogenase (Quinone); NADP; NADPH-Ferrihemoprotein Reductase; NF-E2-Related Factor 2; Oxidative Stress; Paclitaxel; Pentose Phosphate Pathway; Red Fluorescent Protein; Signal Transduction | 2021 |
Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for limited peritoneal metastasis. The PSOGI international collaborative registry.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Colonic Neoplasms; Cytoreduction Surgical Procedures; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Humans; Hyperthermic Intraperitoneal Chemotherapy; Laparoscopy; Length of Stay; Male; Mesothelioma; Middle Aged; Mitomycin; Neoadjuvant Therapy; Neoplasm, Residual; Ovarian Neoplasms; Oxaliplatin; Paclitaxel; Peritoneal Neoplasms; Pseudomyxoma Peritonei; Registries; Severity of Illness Index; Survival Rate; Tumor Burden | 2021 |
Impact of intra-operative factors upon peri-operative outcomes in women undergoing hyperthermic intraperitoneal chemotherapy for gynecologic cancer.
Topics: Acidosis; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cohort Studies; Combined Modality Therapy; Cytoreduction Surgical Procedures; Doxorubicin; Female; Genital Neoplasms, Female; Humans; Hyperthermic Intraperitoneal Chemotherapy; Middle Aged; Mitomycin; Paclitaxel; Perioperative Period; Retrospective Studies | 2021 |
Biological features, gene expression profile, and mechanisms of drug resistance of two- and three-dimensional hepatocellular carcinoma cell cultures.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Culture Techniques; Cell Line, Tumor; Cell Survival; Cisplatin; Cyclin D1; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Minichromosome Maintenance Complex Component 2; Minichromosome Maintenance Complex Component 3; Mitomycin; Paclitaxel; Transcriptome | 2021 |
Singlet Oxygen Activatable Prodrugs of Paclitaxel, SN-38, MMC and CA4: Nonmitochondria-Targeted Prodrugs.
Topics: Antineoplastic Agents; Cell Line, Tumor; Irinotecan; Mitomycin; Paclitaxel; Photochemotherapy; Photosensitizing Agents; Prodrugs; Singlet Oxygen | 2022 |
Improved delivery and competitive adsorption of paclitaxel and mitomycin C anticancer drugs on boron nitride nanoparticles: a molecular dynamics insight.
Topics: Adsorption; Antineoplastic Agents; Boron Compounds; Mitomycin; Molecular Dynamics Simulation; Nanoparticles; Paclitaxel | 2022 |
In silico development and experimental validation of a novel 7-gene signature based on PI3K pathway-related genes in bladder cancer.
Topics: Cisplatin; Deoxyuridine; ErbB Receptors; Gene Expression Regulation, Neoplastic; Humans; Immunoglobulin G; Methotrexate; Mitomycin; Paclitaxel; Phosphatidylinositol 3-Kinases; Tumor Microenvironment; Urinary Bladder Neoplasms; Vinblastine; von Willebrand Factor | 2022 |